Skip to main content

Gino Freddy Sena Ganse

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Gino Freddy Sena Ganse

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercambiador sodio/calcio mitocondrial, NCLX, como estrategia para reducir el daño por isquemia-reperfusión durante un infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Elisabet Miro Casas, Gino Freddy Sena Ganse
Funding agency: FUNDACIÓN ESPAÑOLA DE ARTERIOSCLEROSIS
Funding: 15000
Reference: FEA/RODRIGUEZ/2024
Duration: 01/01/2025 - 31/12/2027

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Elisabet Miro Casas, Marisol Ruiz Meana, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 25000
Reference: FERP/2024/RODRIGUEZ
Duration: 15/01/2025 - 14/01/2027

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio.

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Remedios Rios Barrera, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/00260
Duration: 01/01/2024 - 31/12/2027

Papel de los canales TRPV4 en la fibrosis ventricular derecha: identificación de nuevos mecanismos moleculares y desarrollo de nuevas técnicas de diagnóstico

IP: Begoña Benito Villabriga
Collaborators: Laia Yañez Bisbe, Berta Miranda Barrio, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/01854
Duration: 01/01/2024 - 31/12/2026

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Maria Martinez Pla

Maria Martinez Pla

Main researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Anna Gros Turpin

Anna Gros Turpin

Main researcher
Multidisciplinary Nursing Research Group
Read more
Paula Duch Vega

Paula Duch Vega

Predoctoral researcher
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Susana González Suárez

Susana González Suárez

Postdoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.